Hy Averback

The Committee to Restore Nymox Shareholder Value Provides Factual Update to Nymox Shareholders Regarding Special Meeting

Retrieved on: 
Monday, November 6, 2023
Pharmaceutical, Professional Services, Health, Finance, Supreme court, TRO, Democracy, Human, Committee, Law of the United Kingdom, Exercise, Commonwealth, The, Supreme, Special, Hearing, Order, Security (finance), Management, Hy Averback

For the reasons detailed below, the Special Meeting will be postponed until further court rulings and CRNSV intends to steadfastly and vigorously pursue the urgent holding of the Special Meeting on behalf of all concerned Nymox shareholders within the Bahamian laws.

Key Points: 
  • For the reasons detailed below, the Special Meeting will be postponed until further court rulings and CRNSV intends to steadfastly and vigorously pursue the urgent holding of the Special Meeting on behalf of all concerned Nymox shareholders within the Bahamian laws.
  • Declaring premature and hollow “victories” is a trait of inexperienced and inward-looking leadership that has plagued Nymox for years.
  • Despite having validly called the Special Meeting pursuant to the Bahamian Supreme Court Order, Averback and his submissive Board have attempted to stymie shareholder voices from the very beginning.
  • The Bahamian Supreme Court Order clearly ordered the calling of a shareholder meeting by Nymox and if Nymox did not call the meeting, CRNSV was permitted to do so.

The Committee to Restore Nymox Shareholder Value Reminds All Nymox Pharmaceutical Shareholders to Take Action and Demand Accountability at Upcoming November 8th Special Meeting

Retrieved on: 
Wednesday, November 1, 2023
Health, Pharmaceutical, Supreme court, BY, Attention, Committee, Law of the United Kingdom, Commonwealth, BOARD, The, Supreme, Partnership, Share repurchase, Record, Special, AND, Hy Averback, Arm's length principle, Patient, Order, Letter, Management

As shareholders, collectively, we have been given a critical opportunity to restore Nymox at the upcoming Special Meeting.

Key Points: 
  • As shareholders, collectively, we have been given a critical opportunity to restore Nymox at the upcoming Special Meeting.
  • With the Special Meeting under two weeks away, we encourage shareholders to make their voices heard and act now to install new leadership and a new Board.
  • Unlike the Company’s concerning disregard for compliance with the law, we understand the quorum requirements for holding a shareholder meeting.
  • We believe Nymox shareholders are intelligent and will realize that the Company has attempted to mislead shareholders for years.

Bahamas Supreme Court Rules in Favor of Committee to Restore Nymox Shareholder Value: Orders Shareholder Meeting, Grants Injunction Freezing CEO Shares

Retrieved on: 
Friday, October 6, 2023
Biotechnology, Pharmaceutical, Health, Law of the United Kingdom, The, Commonwealth, Failure, Supreme court, Committee, Letter, Management, Hy Averback

Further, the ruling grants an injunction freezing a significant portion of NYMOX CEO Paul Averback’s (“Averback”) shares, as well as a portion of Director Jim Robinson’s shares, from voting at the shareholder meeting to be convened.

Key Points: 
  • Further, the ruling grants an injunction freezing a significant portion of NYMOX CEO Paul Averback’s (“Averback”) shares, as well as a portion of Director Jim Robinson’s shares, from voting at the shareholder meeting to be convened.
  • Finally, in a separate order, the court restored NYMOX to the Bahamian Company Registry as a proper entity after its previous deregistration in 2018.
  • NYMOX management was apparently unaware that the Company had not been compliant in the Bahamas for over five years.
  • CRNSV will contact each shareholder to confirm participation and support for the changes called for in NYMOX.

Committee to Restore Nymox Shareholder Value Publishes Letters from Nymox Attorneys: Underscores Leadership Attempts to Conceal Information, Invites Shareholders to Join Coalition

Retrieved on: 
Tuesday, August 1, 2023
Professional Services, Health, Other Professional Services, Finance, Pharmaceutical, Biotechnology, Pressure, Failure, RTF, Attention, Committee, FDA, Letter, Management, Security (finance), Hy Averback

Chris Riley, one of the founding members of CRNSV, states, “This style of correspondence points to the secretive, intimidating, and grossly misleading activities taken by NYMOX leadership in an effort to suppress critical information that shareholders should have access to. These published lies are a blatant attempt to divert attention from the real story -- failure to commercialize the company’s product and constant self-dealing by Nymox CEO Averback.”

Key Points: 
  • The Committee to Restore Nymox Shareholder Value, LLC (CRNSV), with a goal to recover shareholder value in NYMOX PHARMACEUTICAL CORP ("NYMX-F"; Company), today invites Nymox shareholders large and small to view the intimidating, threatening letters received by CRNSV members from Nymox attorneys at a dedicated website https://www.crnsv.com/ .
  • Shareholders also saw the partner re-present their proposed Company-saving deal and unanimously accepted it as a sound deal for Nymox to support market access and commercialization efforts.
  • There is no obligation to join or support required and all personal contact information and identification will be confidential and protected.
  • CRNSV will contact each shareholder to confirm participation and support for the changes called for in Nymox.